Shortening of freezing cycles provides equal outcome to standard ablation procedure using second-generation 28 mm cryoballoon after 15-month follow-up

Europace

Volumn 18, Issue 2, 2016, Pages 206-210

  Tebbenjohanns, Jürgen ^a   Höfer, Claudia ^a   Bergmann, Lars ^a   Dedroogh, Michael ^a   Gaudin, Daniela ^a   Von Werder, Axel ^a   Rühmkorf, Klaus ^a  

^a AMEOS Klinikum Hildesheim   (Germany)

Author keywords

Adenosine; Atrial fibrillation; Catheter ablation; Cryoballoon ablation; Phrenic nerve palsy

Indexed keywords

ADENOSINE;

ABLATION CATHETER; ABLATION THERAPY; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVERSION; CATHETER SHEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GUIDE WIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MIDDLE AGED; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; AMBULATORY ELECTROCARDIOGRAPHY; CRYOSURGERY; DEVICES; DISEASE FREE SURVIVAL; EQUIPMENT DESIGN; HEART CATHETER; HEART FUNCTION TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PULMONARY VEIN; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADENOSINE; AGED; ATRIAL FIBRILLATION; CARDIAC CATHETERS; CRYOSURGERY; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY VEINS; QUALITY OF LIFE; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84960405691     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv189     Document Type: Article

References (25)

1. Metzner A, Reissmann BB, Rausch P, Mathew S, Wohlmuth P, Tilz R et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28 mm cryoballoon. Circ Arrhythm Electrophysiol 2014;7:288-92.
2. Chierchia GB, Di Giovanni G, Ciconte G, de Asmundis C, Conte G, Sieira-Moret J et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace 2014;16:639-44.
3. Squara F, Zhao A, Marijon E, Latcu DG, Providencia R, Di Giovanni G et al. Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multi-centre European evaluation. Europace 2015;17:718-24.
4. Martins RP, Hamon D, Césari O, Behaghel A, Behar N, Sellal JM et al. Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm 2014;11:386-93.
5. Straube F, Dorwarth U, Vogt J, Kuniss M, Kuck KH, Tebbenjohanns J et al. Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. Europace 2014;16:1434-42.
6. Casado-Arroyo R, Chierchia GB, Conte G, Levinstein M, Sieira J, Rodriguez-Man'ero M et al. Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first-and second-generation balloon. Heart Rhythm 2013;10:1318-24.
7. Metzner A, Rausch P, Lemes C, Reissmann B, Bardyszewski A, Tilz R et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol 2014;25:466-70.
8. Fürnkranz A, Bordignon S, Schmidt B, Perrotta L, Dugo D, De Lazzari M et al. Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients. Europace 2015;17:574-8.
9. Metzner A, Burchard A, Wohlmuth P, Rausch P, Bardyszewski A, Gienapp C et al. Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 2013;6:769-75.
10. Fürnkranz A, Bordignon S, Schmidt B, Böhmig M, Böhmer MC, Bode F et al. Luminal esophageal temperature predicts esophageal lesions after second-generation cryo-balloon pulmonary vein isolation. Heart Rhythm 2013;10:789-93.
11. Lim HW, Cogert GA, Cameron CS, Cheng VY, Sandler DA. Atrioesophagealfistula during cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2014;25: 208-13.
12. Kawasaki R, Gauri A, Elmouchi D, Duggal M, Bhan A. Atrioesophageal fistula complicating cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2014;25:787-92.
13. Martí-Almor J, Jauregui-Abularach ME, Benito B, Vallès E, Bazan V, Sánchez-Font A et al. Pulmonary hemorrhage after cryoballoon ablation for pulmonary vein isolation in the treatment of atrial fibrillation. Chest 2014;145:156-7.
14. Dorian P, Cvitkoviv SS, Kerr CR, Crystal E, Gillis AM, Guerra PG et al. A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. Can J Cardiol 2006;22:383-6.
15. Chierchia GB, Di Giovanni G, Sieira-Moret J, de Asmundis C, Conte G, Rodriguez-Man'ero M et al. Initial experience of three-minute freeze cycles using the second-generation cryoballoon ablation: acute and short-term procedural outcome. J Interv Card Electrophysiol 2014;39:145-51.
16. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G et al. Single three-minutes freeze for second-generation cryoballoon ablation: one-year follow-up following pulmonary vein isolation. Heart Rhythm 2015;12:673-80.
17. Andrade JG, Dubuc M, Guerra PG, Landry E, Coulombe N, Leduc H et al. Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation. J Cardiovasc Electrophysiol 2013;24:692-8.
18. Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C et al. One-year clinical success of a 'no-bonus' freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace 2015; 17: 1236-40.
19. Ciconte G, Chierchia GB, DE Asmundis C, Sieira J, Conte G, Juliá J et al. Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second generation device. J Cardiovasc Electrophysiol 2014;25: 845-51.
20. Kumar N, Blaauw Y, Timmermans C, Pison L, Vernooy K, Crijns H. Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. J Interv Card Electrophysiol 2014;41:91-7.
21. Van Belle YLE, Janse PA, de Groot NMS, Anné W, Theuns DAMJ, Jordaens LJ. Ad-enosine testing after cryoballoon pulmonary vein isolation improves long-term clinical outcome. Neth Heart J 2012;20:447-55.
22. Fürnkranz A, Bordignon S, Schmidt B, Gunawardene M, Schulte-Hahn B, Urban V et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol 2013;24:492-7.
23. Straube F, Dorwarth U, Schmidt M, Wankerl M, Ebersberger U, Hoffmann E. Comparison of the first and second cryoballoon: high volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol 2014;7:292-9.
24. Kumar N, Dinh T, Phan K, Timmermans C, Philippens S, Dassen W et al. Adenosine testing after second-generation cryoballoon ablation (ATSCA) study improves clinical success rate for atrial fibrillation. Europace 2015;17:871-6.
25. Mc Lellan AJ, Kumar S, Smith C, Morton JB, Kalman JM, Kistler PM. The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a systematic review. J Cardiovasc Electrophysiol 2013; 24:742-51.